Regulator-grade data quality, EHRs and outcome assessment in late-phase clinical trials
A seconded staff member to NHS Digital is looking at the process of data getting from site records into central administrative datasets. This will determine whether these datasets meet the definition of “source data” and, if not, what is the status of these datasets.
Review of applications for routine data complete and the types of trial documented.
Some comparisons of routine and trial-specific data collection (at patient level) completed and systematic review of other examples ongoing.
£650m for UK’s life sciences sector may contribute to improved clinical trials
26 May 2023
HDR UK welcomes the Chancellor of the Exchequer’s pledge of £650 million for the UK’s life sciences including £121 million to improve clinical trials to bring new medicines to patients faster.
EMPA-KIDNEY trial: Effect of empagliflozin on chronic kidney disease progression
7 December 2022
EMPA-KIDNEY is an international clinical trial by Oxford Population Health scientists in collaboration with academics spanning eight countries. The study recruited over 6000 participants to...